BROS vs CRVS · P/E 105, rev $1.02B vs $1.04B cap
Dutch Bros Inc (BROS) versus Corvus Pharmaceuticals Inc (CRVS) — a side-by-side from cached financials, not a winner call.
Dutch Bros Inc (BROS) is a restaurants company listed on NYSE.
Corvus Pharmaceuticals Inc (CRVS) is a biotechnology company listed on US.
Latest reported BROS revenue for 2026-06-30 was $1.02B. Net income was $53.5M. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
CRVS does not have a complete income-statement cache yet.
BROS currently screens at market cap $11.74B and trailing P/E 105.0. CRVS currently screens at market cap $1.04B.
Not investment advice. Open the BROS and CRVS stock pages for the full models.
Not investment advice.